p-selectin antagonist (Novartis)
Structured Review

P Selectin Antagonist, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-selectin+antagonist/p+selectin+inhibitor/pmc10727073-26-0-5
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Using disease-modifying therapies in sickle cell disease"
Article Title: Using disease-modifying therapies in sickle cell disease
Journal: Hematology: the American Society of Hematology Education Program
doi: 10.1182/hematology.2023000485
Figure Legend Snippet: Actively recruiting clinical trials of antioxidants, antiadhesive, and anti-inflammatory agents in SCD
Techniques Used: Clinical Proteomics, Drug discovery, In Vitro, Biomarker Discovery, Saline, Control, Activity Assay, Concentration Assay
Related Articles
Clinical Proteomics:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , Drug discovery:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , In Vitro:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , Biomarker Discovery:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , Saline:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , Control:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , Activity Assay:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , Concentration Assay:Article Title: Using disease-modifying therapies in sickle cell disease Article Snippet: P-selectin antagonist , |